4-(二(2-甲基磺酰基氧乙基)氨基)苯甲醛 | 4248-79-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(二(2-甲基磺酰基氧乙基)氨基)苯甲醛
• 英文名称: p--benzaldehyd
• 英文别名: 4--benzaldehyd；4--benzaldehyd；2-(4-Formyl(2-((methylsulfonyl)oxy)ethyl)anilino)ethyl methanesulfonate；2-[4-formyl-N-(2-methylsulfonyloxyethyl)anilino]ethyl methanesulfonate
• CAS: 4248-79-7
• 化学式: C₁₃H₁₉NO₇S₂
• 分子量: 365.428
• InChiKey: DCAJFQDHDVTBOS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  23
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  124
• 氢给体数：
  0
• 氢受体数：
  8

安全信息

• 海关编码：
  2922399090

文献信息

• Treating or Preventing Renal Cancer Using a Dimethane Sulfonate
  申请人：Mertins Susan D.

  公开号：US20090131536A1

  公开（公告）日：2009-05-21

  The present invention features methods of treating renal cancer by administration of certain dimethylsulfonate compounds. The present invention further features administration protocols and dosing schedules for methods of treating patients suffering from renal cancer and pharmaceutical compositions suitable for use in the treatment methods provided herein.
• TREATING RENAL CANCER USING A 4-[BIS[2-[(METHYLSULFONYL)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE
  申请人：Mertins Susan D.

  公开号：US20110269840A1

  公开（公告）日：2011-11-03

  The present invention features methods of treating a mammalian subject having renal cancer by administration of certain dimethylsulfonate compounds, such as a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde. The present invention further features administration protocols and dosing schedules for methods of treating patients having renal cancer and pharmaceutical compositions suitable for use in the treatment methods provided herein.
• US7989501B2
  申请人：——

  公开号：US7989501B2

  公开（公告）日：2011-08-02
• US8273797B2
  申请人：——

  公开号：US8273797B2

  公开（公告）日：2012-09-25
• [EN] TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE<br/>[FR] TRAITEMENT OU PREVENTION D'UN HYPERNEPHROME EN UTILISANT UN DIMETHANE SULFONATE
  申请人：US GOV HEALTH & HUMAN SERV

  公开号：WO2007044015A9

  公开（公告）日：2007-05-31

  [EN] The present invention features methods of treating renal cancer by administration of certain dimethylsulfonate compounds. The present invention further features administration protocols and dosing schedules for methods of treating patients suffering from renal cancer and pharmaceutical compositions suitable for use in the treatment methods provided herein.
  [FR] La présente invention porte sur des méthodes de traitement d'un hypernéphrome par administration de certains composés de diméthylsulfonate. Cette invention porte également sur des protocole d'administration et sur des posologies prévues pour des méthodes de traitement de patients souffrant d'un hypernéphrome, ainsi que sur des compositions pharmaceutiques appropriées pour être utilisées dans ces méthodes de traitement.